These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15639784)

  • 1. Misfolding promotes the ubiquitination of polyglutamine-expanded ataxin-3, the defective gene product in SCA3/MJD.
    Jana NR; Nukina N
    Neurotox Res; 2004; 6(7-8):523-33. PubMed ID: 15639784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.
    Perez MK; Paulson HL; Pittman RN
    Hum Mol Genet; 1999 Dec; 8(13):2377-85. PubMed ID: 10556285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
    Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
    J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of expanded polyglutamine protein induces behavioral changes in Drosophila (polyglutamine-induced changes in Drosophila).
    Kim YT; Shin SM; Lee WY; Kim GM; Jin DK
    Cell Mol Neurobiol; 2004 Feb; 24(1):109-22. PubMed ID: 15049515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
    Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
    Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
    Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
    Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Yoshizawa T; Yamagishi Y; Koseki N; Goto J; Yoshida H; Shibasaki F; Shoji S; Kanazawa I
    Hum Mol Genet; 2000 Jan; 9(1):69-78. PubMed ID: 10587580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Furusho K; Yoshizawa T; Shoji S
    Neurobiol Dis; 2005 Oct; 20(1):170-8. PubMed ID: 16137577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms to control degradation of polyglutamine-containing protein].
    Nakayama K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):906-8. PubMed ID: 15152500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential susceptibility of cultured cell lines to aggregate formation and cell death produced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Yoshizawa T; Yoshida H; Shoji S
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):349-52. PubMed ID: 11719271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
    Li X; Liu H; Fischhaber PL; Tang TS
    Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
    Tsai HF; Tsai HJ; Hsieh M
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical chaperones reduce aggregate formation and cell death caused by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Yoshida H; Yoshizawa T; Shibasaki F; Shoji S; Kanazawa I
    Neurobiol Dis; 2002 Jul; 10(2):88-99. PubMed ID: 12127147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.
    Perez MK; Paulson HL; Pendse SJ; Saionz SJ; Bonini NM; Pittman RN
    J Cell Biol; 1998 Dec; 143(6):1457-70. PubMed ID: 9852144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machado-Joseph disease/spinocerebellar ataxia type 3.
    Paulson H
    Handb Clin Neurol; 2012; 103():437-49. PubMed ID: 21827905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compromised mitochondrial complex II in models of Machado-Joseph disease.
    Laço MN; Oliveira CR; Paulson HL; Rego AC
    Biochim Biophys Acta; 2012 Feb; 1822(2):139-49. PubMed ID: 22037589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: conclusions from double-transgenic mouse models.
    Hübener J; Riess O
    Neurobiol Dis; 2010 Apr; 38(1):116-24. PubMed ID: 20079840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.